CN115536558A - 一种布美他尼粗品的精制工艺 - Google Patents
一种布美他尼粗品的精制工艺 Download PDFInfo
- Publication number
- CN115536558A CN115536558A CN202211323212.4A CN202211323212A CN115536558A CN 115536558 A CN115536558 A CN 115536558A CN 202211323212 A CN202211323212 A CN 202211323212A CN 115536558 A CN115536558 A CN 115536558A
- Authority
- CN
- China
- Prior art keywords
- bumetanide
- crude
- product
- filtering
- crystallization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MAEIEVLCKWDQJH-UHFFFAOYSA-N bumetanide Chemical compound CCCCNC1=CC(C(O)=O)=CC(S(N)(=O)=O)=C1OC1=CC=CC=C1 MAEIEVLCKWDQJH-UHFFFAOYSA-N 0.000 title claims abstract description 49
- 229960004064 bumetanide Drugs 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000007670 refining Methods 0.000 title claims abstract description 22
- 239000012043 crude product Substances 0.000 title claims abstract description 12
- 239000000047 product Substances 0.000 claims abstract description 26
- 238000002425 crystallisation Methods 0.000 claims abstract description 19
- 230000008025 crystallization Effects 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000001914 filtration Methods 0.000 claims abstract description 10
- 239000003960 organic solvent Substances 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 6
- 239000002798 polar solvent Substances 0.000 claims abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 34
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 2
- 229940011051 isopropyl acetate Drugs 0.000 claims description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000012535 impurity Substances 0.000 abstract description 22
- 238000001514 detection method Methods 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 3
- 230000002829 reductive effect Effects 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 description 9
- 238000006722 reduction reaction Methods 0.000 description 9
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000006208 butylation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 238000006266 etherification reaction Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000006268 reductive amination reaction Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 206010001029 Acute pulmonary oedema Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000005245 nitryl group Chemical group [N+](=O)([O-])* 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
- C07C303/44—Separation; Purification
Abstract
Description
T(min) | A(%) | B(%) |
0 | 60 | 40 |
2 | 60 | 40 |
10 | 20 | 80 |
25 | 20 | 80 |
25.1 | 60 | 40 |
35 | 60 | 40 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211323212.4A CN115536558B (zh) | 2022-10-27 | 2022-10-27 | 一种布美他尼粗品的精制工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211323212.4A CN115536558B (zh) | 2022-10-27 | 2022-10-27 | 一种布美他尼粗品的精制工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115536558A true CN115536558A (zh) | 2022-12-30 |
CN115536558B CN115536558B (zh) | 2024-03-15 |
Family
ID=84718693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211323212.4A Active CN115536558B (zh) | 2022-10-27 | 2022-10-27 | 一种布美他尼粗品的精制工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115536558B (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101033206A (zh) * | 2007-04-13 | 2007-09-12 | 苏州立新制药有限公司 | 一种2-氯-3-硝基-5-羧基苯磺酸酰胺的制备方法 |
CN101591276A (zh) * | 2009-05-21 | 2009-12-02 | 苏州立新制药有限公司 | 一种布美他尼的制备方法 |
JP2011231094A (ja) * | 2009-11-02 | 2011-11-17 | Neurotherapeutics Pharma Inc | ブメタニド、フロセミド、ピレタニド、アゾセミド、およびトルセミドのアナログ、組成物および使用方法 |
US20140066504A1 (en) * | 2012-09-04 | 2014-03-06 | Daryl W. Hochman | Analogs and prodrugs of bumetanide; compositions and methods of use |
CN205528533U (zh) * | 2016-03-18 | 2016-08-31 | 国药集团成都信立邦生物制药有限公司 | 一种布美他尼冻干粉针剂原辅料脱色除炭除菌装置 |
CN106748906A (zh) * | 2016-12-04 | 2017-05-31 | 枣庄市润安制药新材料有限公司 | 一种布美他尼的合成方法 |
CN113735744A (zh) * | 2021-09-08 | 2021-12-03 | 南京卓康医药科技有限公司 | 一种布美他尼的中间体的合成方法 |
-
2022
- 2022-10-27 CN CN202211323212.4A patent/CN115536558B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101033206A (zh) * | 2007-04-13 | 2007-09-12 | 苏州立新制药有限公司 | 一种2-氯-3-硝基-5-羧基苯磺酸酰胺的制备方法 |
CN101591276A (zh) * | 2009-05-21 | 2009-12-02 | 苏州立新制药有限公司 | 一种布美他尼的制备方法 |
JP2011231094A (ja) * | 2009-11-02 | 2011-11-17 | Neurotherapeutics Pharma Inc | ブメタニド、フロセミド、ピレタニド、アゾセミド、およびトルセミドのアナログ、組成物および使用方法 |
US20140066504A1 (en) * | 2012-09-04 | 2014-03-06 | Daryl W. Hochman | Analogs and prodrugs of bumetanide; compositions and methods of use |
CN205528533U (zh) * | 2016-03-18 | 2016-08-31 | 国药集团成都信立邦生物制药有限公司 | 一种布美他尼冻干粉针剂原辅料脱色除炭除菌装置 |
CN106748906A (zh) * | 2016-12-04 | 2017-05-31 | 枣庄市润安制药新材料有限公司 | 一种布美他尼的合成方法 |
CN113735744A (zh) * | 2021-09-08 | 2021-12-03 | 南京卓康医药科技有限公司 | 一种布美他尼的中间体的合成方法 |
Non-Patent Citations (1)
Title |
---|
李飞主编: "药物化学实验", 华中科技大学出版社, pages: 15 - 17 * |
Also Published As
Publication number | Publication date |
---|---|
CN115536558B (zh) | 2024-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108503621B (zh) | 一种富马酸沃诺拉赞的制备方法 | |
CN103073438B (zh) | 一种盐酸氨溴索化合物的精制方法 | |
CN107793418A (zh) | 一种枸橼酸托法替布的工业化生产方法 | |
CN106256824B (zh) | 一种高纯度德拉沙星葡甲胺盐的制备方法 | |
CN107915586B (zh) | 一种苯酚化合物及制备方法 | |
CN111792981B (zh) | 一种大麻二酚的提纯方法 | |
CN115536558A (zh) | 一种布美他尼粗品的精制工艺 | |
CN112142604A (zh) | 一种盐酸溴己新及其中间体的制备方法 | |
CN106883227B (zh) | 通过麦角菌发酵废料制备麦角新碱的方法 | |
WO2020010765A1 (zh) | 一种特布他林中间体的合成方法 | |
CN111100042B (zh) | 一种2-甲氧基-5-磺酰胺基苯甲酸的制备方法 | |
CN110938075B (zh) | 一种更昔洛韦的制备方法 | |
CN104876812B (zh) | 制备盐酸舍曲林中间体及杂质的方法 | |
CN110746378B (zh) | 一种胺基中间体的制备方法 | |
CN112645901A (zh) | 一种1-环己基哌嗪的制备方法 | |
CN107325070B (zh) | 一种2,3,4-三-o-苄基-6-脱氧-d-吡喃葡萄糖酸-1,5-内酯的制备方法 | |
CN104650048B (zh) | 一种奥美沙坦酯缩合物的纯化方法 | |
CN104817546B (zh) | 一种奥美沙坦酯母液回收的方法 | |
CN110862429A (zh) | 一种七叶皂苷钠的制备方法 | |
CN112062684B (zh) | 一种沙丁胺醇中间体iv的纯化方法 | |
CN117209387B (zh) | 一种盐酸艾司洛尔的成盐及纯化工艺 | |
CN113121466B (zh) | 盐酸阿考替胺的重结晶溶剂及其精制方法 | |
CN109422702A (zh) | 赖诺普利中间体及其纯化方法 | |
CN107935876B (zh) | 一种2-(3-氨基-4-氯苯甲酰)苯甲酸的制备方法 | |
CN108069971B (zh) | 一种普拉曲沙中间体的精制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230703 Address after: 311121 Room 688, Block C, No. 8-1 Gaoshun Road, Wuchang Subdistrict, Yuhang District, Hangzhou City, Zhejiang Province Applicant after: Pengshang medicine (Hangzhou) Co.,Ltd. Applicant after: Hangzhou Muyuan Biomedical Technology Co.,Ltd. Applicant after: Zhejiang hemukang Pharmaceutical Technology Co.,Ltd. Address before: 311121 room 1301-1310, building B, Zhengyuan wisdom, No. 359, Shuxin Road, Cangqian street, Yuhang District, Hangzhou City, Zhejiang Province Applicant before: Hangzhou Muyuan Biomedical Technology Co.,Ltd. Applicant before: Zhejiang hemukang Pharmaceutical Technology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |